| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |